A novel chromatin regulator-related immune checkpoint related gene prognostic signature and potential candidate drugs for endometrial cancer patients

BACKGROUND: Endometrial cancer (EC) is the most common gynecologic malignancy in developed countries and its prevalence is increasing. As an emerging therapy with a promising efficacy, immunotherapy has been extensively applied in the treatment of solid tumors. In addition, chromatin regulators (CRs...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zesi, Yang, Hongxia, Chen, Ziyu, Jing, Chunli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578220/
https://www.ncbi.nlm.nih.gov/pubmed/36253800
http://dx.doi.org/10.1186/s41065-022-00253-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578220/
https://www.ncbi.nlm.nih.gov/pubmed/36253800
http://dx.doi.org/10.1186/s41065-022-00253-w

Ejemplares similares